Literature DB >> 16714253

Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: an approach to optimize procedures for clinical use.

G Cui1, T Olsen, I Christiansen, B Vonen, J Florholmen, R Goll.   

Abstract

OBJECTIVE: The precise measurement of local tumor necrosis factor alpha (TNF-alpha) expression in tissue is important in understanding the pathogenesis of inflammatory bowel diseases (IBD). Real-time polymerase chain reaction (PCR) is a sensitive, versatile method and is becoming a commonly used tool for the quantification of gene expression. The aim of this study was to optimize the laboratory procedure for biopsy sampling, storage and calibration of result for TNF-alpha mRNA quantification with real-time PCR of colorectal biopsies.
MATERIAL AND METHODS: Endoscopic biopsies from the colorectum were obtained from 18 patients with ulcerative colitis (UC), 11 patients with Crohn's disease (CD) and 18 normal controls. Optimization of procedures for real-time PCR performance was carried out.
RESULTS: The transport medium, RNAlater, exhibited a high preservation effect against RNA degradation even after 8 days of storage at room temperature; one biopsy from each patient was sufficient for RNA extraction, cDNA synthesis and TNF-mRNA quantification. An assay was established with a technical reproducible sensitivity of 100 copies/microL. The observed interassay variations were 7.4 % coefficient of variation (CV) and 7.2 % CV in low and high TNF-alpha mRNA expression biopsies, respectively. TNF-alpha mRNA levels in colorectal biopsies from patients with either CD or moderate to severe UC were markedly increased, and 8 approximately 9-fold higher than those in healthy controls.
CONCLUSIONS: This optimization improves the clinical use of real-time PCR for quantification of TNF-alpha gene expression in colorectal biopsies and provides a sensitive reproducible assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714253     DOI: 10.1080/00365510600590472

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

1.  Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

Authors:  Jon Sponheim; Jürgen Pollheimer; Trine Olsen; Johanna Balogh; Clara Hammarström; Tamara Loos; Monika Kasprzycka; Dag Reidar Sørensen; Hogne Røed Nilsen; Axel M Küchler; Morten H Vatn; Guttorm Haraldsen
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

2.  Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence.

Authors:  Guanglin Cui; Hang Yang; Jianbo Zhao; Aping Yuan; Jon Florholmen
Journal:  Pathol Oncol Res       Date:  2014-05-25       Impact factor: 3.201

Review 3.  Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?

Authors:  Guanglin Cui; Jon Florholmen; Rasmus Goll
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

Review 4.  Crohn's disease: an immune deficiency state.

Authors:  Daniel J B Marks; Farooq Z Rahman; Gavin W Sewell; Anthony W Segal
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

5.  Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease.

Authors:  Sara Bogaert; Debby Laukens; Harald Peeters; Lode Melis; Kim Olievier; Nico Boon; Gust Verbruggen; Jo Vandesompele; Dirk Elewaut; Martine De Vos
Journal:  BMC Immunol       Date:  2010-12-13       Impact factor: 3.615

6.  Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.

Authors:  Mona Dixon Gundersen; Rasmus Goll; Johanna Hol; Trine Olsen; Renathe Rismo; Sveinung W Sørbye; Olav Sundnes; Guttorm Haraldsen; Jon Florholmen
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

7.  Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects.

Authors:  Ewa Żyła; Katarzyna Dziendzikowska; Dariusz Kamola; Jacek Wilczak; Rafał Sapierzyński; Joanna Harasym; Joanna Gromadzka-Ostrowska
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

8.  ST2 and regulatory T cells in the colorectal adenoma/carcinoma microenvironment: implications for diseases progression and prognosis.

Authors:  Guanglin Cui; Aping Yuan; Zhenfeng Li; Rasmus Goll; Jon Florholmen
Journal:  Sci Rep       Date:  2020-04-03       Impact factor: 4.379

9.  Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis.

Authors:  Jon R Florholmen; Kay-Martin Johnsen; Renate Meyer; Trine Olsen; Øystein K Moe; Petter Tandberg; Mona D Gundersen; Jan-Magnus Kvamme; Knut Johnsen; Terje Løitegård; Gabriele Raschpichler; Cecilia Vold; Sveinung W Sørbye; Rasmus Goll
Journal:  BMC Gastroenterol       Date:  2020-10-02       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.